Does RILMENIDINE Cause Interstitial lung disease? 8 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Interstitial lung disease have been filed in association with RILMENIDINE. This represents 0.9% of all adverse event reports for RILMENIDINE.
8
Reports of Interstitial lung disease with RILMENIDINE
0.9%
of all RILMENIDINE reports
0
Deaths
8
Hospitalizations
How Dangerous Is Interstitial lung disease From RILMENIDINE?
Of the 8 reports, 8 (100.0%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RILMENIDINE. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does RILMENIDINE Cause?
Acute kidney injury (214)
Lactic acidosis (121)
Fall (120)
Hyperkalaemia (86)
Hypotension (85)
Hypoglycaemia (59)
Diarrhoea (49)
Bradycardia (45)
Rhabdomyolysis (44)
Drug ineffective (41)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which RILMENIDINE Alternatives Have Lower Interstitial lung disease Risk?
RILMENIDINE vs RILONACEPT
RILMENIDINE vs RILPIVIRINE
RILMENIDINE vs RILUZOLE
RILMENIDINE vs RIMABOTULINUMTOXINB
RILMENIDINE vs RIMEGEPANT